title: Home telemonitoring study for Japanese patients with heart failure (HOMES-HF): protocol for a multicentre randomised controlled trial.
abstract: BACKGROUND
  Despite the encouraging results from several randomised controlled trials (RCTs) and meta-analyses, the ability of home telemonitoring for heart failure (HF) to improve patient outcomes remains controversial as a consequence of the two recent large-scale RCTs. However, it has been suggested that there is a subgroup of patients with HF who may benefit from telemonitoring. The aim of the present study was to investigate whether an HF management programme using telemonitoring could improve outcomes in patients with HF under the Japanese healthcare system.
  
  
  METHODS
  The Home Telemonitoring Study for Japanese Patients with Heart Failure (HOMES-HF) study is a prospective, multicentre RCT to investigate the effectiveness of home telemonitoring on the primary composite endpoint of all-cause death and rehospitalisation due to worsening HF in recently admitted HF patients (aged 20 and older, New York Heart Association classes II-III). The telemonitoring system is an automated physiological monitoring system including body weight, blood pressure and pulse rate by full-time nurses 7 days a week. Additionally, the system was designed to make it a high priority to support patient's self-care instead of an early detection of HF decompensation. A total sample size of 420 patients is planned according to the Schoenfeld and Richter method. Eligible patients are randomly assigned via a website to either the telemonitoring group or the usual care group by using a minimisation method with biased-coin assignment balancing on age, left ventricular ejection fraction and a history of ischaemic heart disease. Participants will be enrolled until August 2013 and followed until August 2014. Time to events will be estimated using the Kaplan-Meier method, and HRs and 95% CIs will be calculated using the Cox proportional hazards models with stratification factors.
  
  
  BACKGROUND
  The study is registered at UMIN Clinical Trials Registry (UMIN000006839).
authors.affiliation: Department of Cardiovascular Medicine, Saga University, Saga, Japan.
authors.forename: Norihiko
authors.initials: N
authors.lastname: Kotooka
authors.forename: Machiko
authors.initials: M
authors.lastname: Asaka
authors.forename: Yasunori
authors.initials: Y
authors.lastname: Sato
authors.forename: Yoshiharu
authors.initials: Y
authors.lastname: Kinugasa
authors.forename: Kotaro
authors.initials: K
authors.lastname: Nochioka
authors.forename: Atsushi
authors.initials: A
authors.lastname: Mizuno
authors.forename: Daisuke
authors.initials: D
authors.lastname: Nagatomo
authors.forename: Daigo
authors.initials: D
authors.lastname: Mine
authors.forename: Yoko
authors.initials: Y
authors.lastname: Yamada
authors.forename: Kazuo
authors.initials: K
authors.lastname: Eguchi
authors.forename: Hideki
authors.initials: H
authors.lastname: Hanaoka
authors.forename: Takayuki
authors.initials: T
authors.lastname: Inomata
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Fukumoto
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Tsutsui
authors.forename: Tohru
authors.initials: T
authors.lastname: Masuyama
authors.forename: Masafumi
authors.initials: M
authors.lastname: Kitakaze
authors.forename: Teruo
authors.initials: T
authors.lastname: Inoue
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Shimokawa
authors.forename: Shin-Ichi
authors.initials: S
authors.lastname: Momomura
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Seino
authors.forename: Koichi
authors.initials: K
authors.lastname: Node